Evidence map›Paper›PMID 18406118›Full record

ArticleEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V2008

Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers.

Rana Bahhady, Kwang-Jin Kim, Zea Borok, Edward D Crandall, Wei-Chiang Shen

Open access · greenAbstract read
In one paragraph

Article in European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rana BahhadyDepartment of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089-9121, USA.
Kwang-Jin Kim
Zea Borok
Edward D Crandall
Wei-Chiang Shen
University of Southern California · USRogers (United States) · US

Funding

ABSORPTION MECHANISMS FOR PEPTIDE/PROTEIN DRUGS VIA LUNGR01HL064365 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CRANDALL, EDWARD DAVID · 1999 to 2008
$6.3M
Role of ATI cells in alveolar epithelial ion transportR01HL038621 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CRANDALL, EDWARD DAVID · 1986 to 2010
$3.2M
Role of FoxP2 in AEC (trans)differentiationR01HL062569 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA · 2000 to 2008
$2.8M
Molecular programming of AEC differentiation: role of forkhead factorsR37HL062569 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BOROK, ZEA · 2010 to 2014
$2.2M
REGULATION OF ALVEOLAR EPITHELIAL CELL DIFFERENTIATIONR01HL038578 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI BOROK, ZEA · 1986 to 2007
$1.7M
Regulation of lung alveolar epithelial protein transportR01HL038658 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI KIM, KWANG-JIN · 1989 to 2005
$1.4M
LUNG EPITHELIAL TRANSPORT PROPERTIES AND ALVEOLAR EDEMAR37HL038578 · NHLBI · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI CRANDALL, EDWARD DAVID · 1987 to 1996
–
NHLBI NIH HHS HL38578NHLBI NIH HHS HL38621NHLBI NIH HHS HL38658NHLBI NIH HHS HL62569NHLBI NIH HHS HL64365NHLBI NIH HHS R01 HL038578NHLBI NIH HHS R01 HL038621NHLBI NIH HHS R01 HL038658NHLBI NIH HHS R01 HL062569NHLBI NIH HHS R01 HL064365NHLBI NIH HHS R37 HL062569
6 · The paper itself

Abstract

The aim of this study was to characterize factor(s) in rat bronchoalveolar lavage fluid (BALF) that enhance(s) insulin transport across primary rat alveolar epithelial cell monolayers (RAECM) in primary culture. BALF was concentrated 7.5-fold using the Centricon device and the retentate was used to characterize the factor(s) involved in enhancing apical-to-basolateral transport of intact 125I-insulin across various epithelial cell monolayers. These factor(s) enhanced transport of intact insulin across type II cell-like RAECM (3-fold increase) and type I cell-like RAECM (2-fold increase), but not across Caco-2 or MDCK cell monolayers. The insulin transport-enhancing factor(s) were temperature- and trypsin-sensitive. The mechanism of enhancement did not seem to involve paracellular transport or fluid-phase endocytosis, since fluxes of sodium fluorescein and FITC-dextran (70 kDa) were not affected by the factor(s) in the apical bathing fluid. BALF enhancement of intact 125I-insulin transport was abolished at 4 degrees C and in the presence of monensin, suggesting involvement of transcellular pathways. Sephacryl S-200 purification of BALF retentate, followed by LC-MS/MS, indicated that the high molecular weight (>100 kDa) fractions (which show some homology to alpha-1-inhibitor III, murinoglobulin gamma 2, and pregnancy-zone protein) appear to facilitate transcellular transport of insulin across RAECM.

Indexed as

AbsorptionAnimalsBiological Transport, ActiveBronchoalveolar Lavage FluidCaco-2 CellsCell LineCells, CulturedDatabases, GeneticDextransDogsEndocytosisEpithelial CellsFluorescein-5-isothiocyanateFluorescent DyesHumansInsulinDextransFluorescein-5-isothiocyanatefluorescein isothiocyanate dextranFluorescent DyesInsulinPeptidesTrypsin

Identifiers

PMID18406118
PMCPMC3638983
OpenAlexW2005179225

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.